Suppr超能文献

双心室辅助装置作为围产期心肌病治疗中过渡到心脏移植的桥梁。

Biventricular assist device as a bridge to cardiac transplantation in the treatment of peripartum cardiomyopathy.

作者信息

Lewis R, Mabie W C, Burlew B, Sibai B M

机构信息

Department of Obstetrics and Gynecology, University of Tennessee, Memphis, USA.

出版信息

South Med J. 1997 Sep;90(9):955-8. doi: 10.1097/00007611-199709000-00021.

Abstract

Peripartum cardiomyopathy is an unexpected complication of the puerperium with a high mortality rate. Appropriate therapy requires accurate identification of this disease, which is frequently difficult in a patient who has been previously healthy. Medical therapy using alteration of intravascular volume (to optimize ventricular preload), the addition of inotropic agents (to correct ventricular function), and intra-aortic balloon counterpulsation (to improve afterload reduction) is the first line of therapy. Surgical therapy, involving cardiac transplantation, is the ultimate treatment. This therapeutic modality, however, is limited by a lack of available organs for transplant. The development of devices to be used as a "bridge" is gaining acceptance and use as a pretransplantation procedure. This use may be considered particularly fundamental in otherwise healthy young women with peripartum cardiomyopathy. These patients frequently can have almost complete recovery and rehabilitation. We report the case of a young woman with peripartum cardiomyopathy who had a favorable outcome. We performed medical and surgical therapy, insertion of a temporary "bridge" device, and ultimately cardiac transplantation.

摘要

围产期心肌病是产褥期一种意想不到的并发症,死亡率很高。恰当的治疗需要准确识别这种疾病,而这对于既往健康的患者来说常常很困难。通过改变血管内容量(以优化心室前负荷)、添加正性肌力药物(以纠正心室功能)以及主动脉内球囊反搏(以改善后负荷降低)进行药物治疗是一线治疗方法。涉及心脏移植的手术治疗是最终的治疗手段。然而,这种治疗方式受到缺乏可用移植器官的限制。用作“桥梁”的装置的开发作为一种移植前程序正越来越被接受和使用。在患有围产期心肌病的其他方面健康的年轻女性中,这种应用可能被认为尤为重要。这些患者常常能够几乎完全康复和恢复。我们报告了一例患有围产期心肌病且预后良好的年轻女性病例。我们进行了药物和手术治疗、插入临时“桥梁”装置,并最终进行了心脏移植。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验